Related Experiment Video
Updated: Jun 17, 2025
Monitoring Dynamic Growth of Retinal Vessels in Oxygen-Induced Retinopathy Mouse Model
Published on: April 2, 2021
Natural Products in the Treatment of Retinopathy of Prematurity: Exploring Therapeutic Potentials
1College of Pharmacy and Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu 41566, Republic of Korea.
Insights
Retinopathy of prematurity (ROP) is a serious eye condition in premature infants. This review explores natural products as potential treatments for ROP, offering hope for safer therapies.
Area of Science:
- Ophthalmology
- Neonatology
- Pharmacology
Background:
- Retinopathy of prematurity (ROP) is a vascular disorder impacting preterm infant retinas.
- High oxygen exposure in incubators triggers oxidative stress and capillary loss, leading to abnormal blood vessel growth.
- ROP is a growing cause of childhood blindness, with current treatments having significant adverse effects.
Purpose of the Study:
- To review the potential of natural products in managing retinopathy of prematurity.
- To discuss the mechanisms of action for natural products in ROP therapy.
Main Methods:
- Literature review of scientific studies on natural products and ROP.
- Analysis of the pathophysiology of ROP and the role of vascular endothelial growth factors.
- Examination of the therapeutic properties and minimal side effects of natural compounds.
Main Results:
- Natural products from diverse sources (plants, fungi, bacteria, marine organisms) show promise for ROP.
- These agents possess beneficial properties and minimal side effects compared to conventional treatments.
- Understanding their roles and mechanisms is crucial for developing innovative ROP therapies.
Conclusions:
- Natural products represent a promising avenue for novel ROP treatments.
- Further research into these agents could lead to safer and more effective interventions for preventing childhood blindness.
Abstract:
Retinopathy of prematurity (ROP) is a vascular disorder affecting the retinas of preterm infants. This condition arises when preterm infants in incubators are exposed to high oxygen levels, leading to oxidative stress, inflammatory responses, and a downregulation of vascular endothelial growth factors, which causes the loss of retinal microvascular capillaries. Upon returning to room air, the upregulation of vascular growth factors results in abnormal vascular growth of retinal endothelial cells. Without appropriate intervention, ROP can progress to blindness. The prevalence of ROP has risen, making it a significant cause of childhood blindness. Current treatments, such as laser therapy and various pharmacologic approaches, are limited by their potential for severe adverse effects. Therefore, a deeper understanding of ROP's pathophysiology and the development of innovative treatments are imperative. Natural products from plants, fungi, bacteria, and marine organisms have shown promise in treating various diseases and have gained attention in ROP research due to their minimal side effects and wide-ranging beneficial properties. This review discusses the roles and mechanisms of natural products that hold potential as therapeutic agents in ROP management.
